Harmony Biosciences Holdings (HRMY) Long-Term Deferred Tax (2022 - 2025)
Historic Long-Term Deferred Tax for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to $157.1 million.
- Harmony Biosciences Holdings' Long-Term Deferred Tax fell 1510.19% to $157.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.1 million, marking a year-over-year decrease of 1510.19%. This contributed to the annual value of $190.4 million for FY2024, which is 3207.23% up from last year.
- Harmony Biosciences Holdings' Long-Term Deferred Tax amounted to $157.1 million in Q3 2025, which was down 1510.19% from $201.2 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Long-Term Deferred Tax ranged from a high of $201.2 million in Q2 2025 and a low of $81.7 million during Q3 2022
- In the last 4 years, Harmony Biosciences Holdings' Long-Term Deferred Tax had a median value of $147.6 million in 2024 and averaged $142.4 million.
- Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 9255.17% in 2024, then plummeted by 1510.19% in 2025.
- Harmony Biosciences Holdings' Long-Term Deferred Tax (Quarter) stood at $85.9 million in 2022, then soared by 67.74% to $144.2 million in 2023, then surged by 32.07% to $190.4 million in 2024, then dropped by 17.5% to $157.1 million in 2025.
- Its Long-Term Deferred Tax was $157.1 million in Q3 2025, compared to $201.2 million in Q2 2025 and $194.7 million in Q1 2025.